Zotiraciclib Uses, Dosage, Side Effects and more
Zotiraciclib is under investigation in clinical trial NCT02942264 (Zotiraciclib (TG02) Plus Dose-dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma).
Trade Name | Zotiraciclib |
Generic | Zotiraciclib |
Type | |
Formula | C23H24N4O |
Weight | Average: 372.472 Monoisotopic: 372.195011409 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |